With pharmaceutical and biopharmaceutical manufacturers preparing for the implementation of US Pharmacopeia (USP) 665 on May 1, 2026, understanding the chapter’s requirements and practical implications is more important than ever. USP 665 outlines a risk-based framework for evaluating plastic components used in single-use and multi-use systems, with a focus on extractables and leachables (E&L) – a critical aspect of product safety and regulatory compliance.

To help the industry navigate this transition, we are hosting a live expert roundtable discussion featuring specialists from SGS and a special guest, Dr. Desmond Hunt, Senior Principal Scientist at USP and a recognized authority in pharmaceutical packaging, particulate matter in dosage forms and best practices in storage and transportation.

This is a unique opportunity to hear directly from USP and to engage with experts who have supported hundreds of E&L projects across the globe.

Agenda

Introductions
Overview of USP 665
Roundtable-style, conversational discussion: expert insights addressing the most common and challenging questions raised across hundreds of customer projects
Live Q&A

Who should attend?

The webinar is tailored for suppliers of single-use systems, (bio) pharmaceutical manufacturers, process engineers, production scientists, pharmacists, quality assurance and regulatory affairs professionals, E&L specialists and anyone exploring outsourced E&L testing solutions.

This event takes place on November 20, 2025, at 2:00 PM GMT.